Shell Asset Management Co. Sells 7,139 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Shell Asset Management Co. lessened its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 135,867 shares of the pharmacy operator’s stock after selling 7,139 shares during the quarter. Shell Asset Management Co.’s holdings in Walgreens Boots Alliance were worth $6,216,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Savant Capital LLC grew its position in Walgreens Boots Alliance by 87.2% in the 1st quarter. Savant Capital LLC now owns 30,824 shares of the pharmacy operator’s stock valued at $1,410,000 after acquiring an additional 14,359 shares during the last quarter. ING Groep NV grew its position in shares of Walgreens Boots Alliance by 46.0% during the 4th quarter. ING Groep NV now owns 57,426 shares of the pharmacy operator’s stock worth $3,386,000 after buying an additional 18,085 shares in the last quarter. Great Lakes Advisors LLC grew its position in shares of Walgreens Boots Alliance by 74.2% during the 4th quarter. Great Lakes Advisors LLC now owns 13,701 shares of the pharmacy operator’s stock worth $808,000 after buying an additional 5,835 shares in the last quarter. Hartford Investment Management Co. grew its position in shares of Walgreens Boots Alliance by 3.4% during the 4th quarter. Hartford Investment Management Co. now owns 120,397 shares of the pharmacy operator’s stock worth $7,099,000 after buying an additional 4,007 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its position in shares of Walgreens Boots Alliance by 27.3% during the 1st quarter. Assenagon Asset Management S.A. now owns 233,075 shares of the pharmacy operator’s stock worth $10,663,000 after buying an additional 49,936 shares in the last quarter. 58.03% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance stock traded down $0.15 during midday trading on Friday, reaching $39.60. The company’s stock had a trading volume of 3,378,765 shares, compared to its average volume of 7,383,946. The stock’s 50-day simple moving average is $42.22 and its 200-day simple moving average is $51.33. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. Walgreens Boots Alliance Inc has a 52-week low of $36.65 and a 52-week high of $64.50. The stock has a market capitalization of $34.87 billion, a P/E ratio of 6.87, a PEG ratio of 1.83 and a beta of 0.55.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion during the quarter, compared to analysts’ expectations of $35.24 billion. During the same period last year, the business posted $1.64 earnings per share. The firm’s revenue was up 3.7% compared to the same quarter last year. As a group, equities research analysts expect that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be paid a $0.4575 dividend. This represents a $1.83 dividend on an annualized basis and a yield of 4.62%. The ex-dividend date of this dividend is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.

WBA has been the topic of a number of recent research reports. Deutsche Bank raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and dropped their price target for the stock from $51.00 to $43.00 in a research report on Friday, April 3rd. Royal Bank of Canada dropped their price target on Walgreens Boots Alliance from $57.00 to $48.00 and set a “sector perform” rating on the stock in a research report on Friday, April 3rd. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating on the stock in a research report on Friday, April 3rd. ValuEngine downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, March 3rd. Finally, Cowen decreased their price objective on Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating for the company in a research note on Tuesday. Four research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $51.21.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Why Invest in High-Yield Dividend Stocks?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.